JAMA Surgery Publishes Landmark BrIMA Study Demonstrating Significant Improvement in Intraoperative Margin Assessment with Specimen PET-CT
GHENT, BELGIUM — XEOS, a medical technology company advancing intraoperative molecular imaging, today announced the publication of the BrIMA (Breast cancer Intraoperative Margin Assessment) study in JAMA Surgery, world’s leading…



